Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

INDUSTRY 2 OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Brain Neoplasms 1

Interventions

Temozolomide 400 Radiotherapy 238 Bevacizumab 184 Magnetic Resonance Spectroscopy 167 Radiosurgery 141 Cyclophosphamide 95 Irinotecan 79 Carboplatin 79 Etoposide 78 Radiation 75 pembrolizumab 69 Nivolumab 59 Surgical Procedures, Operative 57 Filgrastim 56 Specimen Handling 53 Cisplatin 50 Blood Specimen Collection 46 Topotecan 45 Vincristine 43 Melphalan 38 Radiotherapy, Intensity-Modulated 36 Pemetrexed 36 Ipilimumab 36 Lomustine 35 Everolimus 35 Magnetic Resonance Imaging 34 Erlotinib Hydrochloride 34 Drug Therapy 34 Surveys and Questionnaires 33 sargramostim 30

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × iniparib × CNS × Clear all

NCT01551680 2025-02-13

RAPIBE

Institut du Cancer de Montpellier - Val d'Aurelle

Phase 1 Terminated

Brain Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡